Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00161824
Status:
COMPLETED
Last Update Posted:
2015-05-21
First Post:
2005-09-08
Brief Title:
Safety Study in Volunteers From 16 to 65 Years of Age FSME IMMUN NEW vs ENCEPUR
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Single-blind Randomized Multicenter Comparison of FSME IMMUN NEW and ENCEPUR Safety and Tolerability of Two Vaccinations in Healthy Volunteers Aged 16 to 65 Years
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the safety of a vaccination schedule consisting of two vaccinations 21-35 days apart with the tick-borne encephalitis TBE vaccine FSME-IMMUN NEW 5 consecutive lots in comparison to another licensed TBE vaccine Encepur adults with polygeline 2 lots in healthy volunteers aged 16 to 65 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None